Clinical evaluation of Dyslipidemia among type II diabetic patients at Public hospital Penang, Malaysia

Table 4 Complications association with combination regimen among Cohort

Regimen design	Complications N/Total. (%)	χ² value ǂ
Metformin (monotherapy)	94/105. (89.5)	0.001
Lovastatin (monotherapy)	364/416. (87.5)	0.001
Sulfonlyurea	336/384. (87.5)	0.023
Insulin	70/73. (95.9)	0.001
Insulin & Oral hyperglycemic agent	61/64. (95.3)	0.001
Metformin & Diuretics	95/95. (100.0)	0.000
Metformin & Calcium Channel block	17/17. (100.0)	0.000
Metformin & Digoxin	2/2. (100.0)	0.000
Metformin & corticosteroid	9/9. (100.0)	0.000
Metformin & Nefidine	87/87. (100.0)	0.000
Lovastatin & Gemfibrozil	17/17. (100.0)	0.000
Lovastatin & other combinations	61/68. (89.7)	0.018

ǂ all the variables were in 2 × 2 type (as. Metformin = monoXcomb..etc), Similarly complications section is dictomise into (yes & no). Sig. value is taken on individual analysis latter compressed in this table